Senseonics Holdings, Inc. (SENS)

NYSEAMERICAN: SENS · IEX Real-Time Price · USD
1.20
-0.05 (-4.00%)
Feb 3, 2023, 4:00 PM EST - Market closed
-4%
Market Cap 573.91M
Revenue (ttm) 14.83M
Net Income (ttm) 214.99M
Shares Out 478.26M
EPS (ttm) 0.02
PE Ratio 60.00
Forward PE 21.51
Dividend n/a
Ex-Dividend Date n/a
Volume 2,755,544
Open 1.21
Previous Close 1.25
Day's Range 1.19 - 1.27
52-Week Range 0.77 - 3.89
Beta 0.88
Analysts Sell
Price Target 2.07 (+72.5%)
Earnings Date Feb 27, 2023

About SENS

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serve... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 89
Stock Exchange NYSEAMERICAN
Ticker Symbol SENS
Full Company Profile

Financial Performance

In 2021, SENS's revenue was $13.68 million, an increase of 176.32% compared to the previous year's $4.95 million. Losses were -$302.47 million, 72.7% more than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for SENS stock is "Sell." The 12-month stock price forecast is $2.07, which is an increase of 72.50% from the latest price.

Price Target
$2.07
(72.50% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Senseonics Announces Equity Grants To Employees Under Inducement Plan

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous gluc...

1 month ago - Business Wire

7 Penny Stocks That Actually Have Buy Ratings

This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about  companies that retail investors cannot obtain.

2 months ago - InvestorPlace

Senseonics to Present at the Stifel 2022 Healthcare Conference

GERMANTOWN, Md.

3 months ago - Business Wire

Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)

First patients have been served, launching the Nurse Practitioner Group partnership to expedite and expand access to the Eversense® E3 CGM GERMANTOWN, Md. , Nov. 3, 2022 /PRNewswire/ -- Senseonics Hol...

3 months ago - PRNewsWire

Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

5 months ago - Business Wire

Senseonics Announces CFO Transition

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

5 months ago - Business Wire

Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose...

6 months ago - Business Wire

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Senseonics Holdings, Inc. Reports Second Quarter 2022 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

6 months ago - Business Wire

Why Is Senseonics (SENS) Stock Heating Up Today?

Senseonics (NYSEAMERICAN: SENS) stock jumped by over 50% after it announced its Eversense implantable glucose monitor was approved for coverage by Elevance Health (NYSE: ELV), formerly known as Anth...

6 months ago - InvestorPlace

Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose...

6 months ago - Business Wire

Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose...

6 months ago - Business Wire

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose...

8 months ago - Business Wire

7 Undervalued Penny Stocks to Buy for Massive Gains

These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. The post 7 Undervalued Penny Stocks to Buy for Massive Gains appeared first on InvestorP...

Other symbols: CIDMGHSIIDEXMUXSHIP
8 months ago - InvestorPlace

Senseonics to Participate in the Jefferies Healthcare Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

9 months ago - Business Wire

Senseonics to Participate in the H.C. Wainwright Global Investment Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

9 months ago - Business Wire

Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

9 months ago - Business Wire

3 Zombie Companies That Still Have Hope for New Life

The unprecedented expansionary fiscal and monetary policies during the pandemic may have caused a significant surge in zombie companies. The post 3 Zombie Companies That Still Have Hope for New Life a...

Other symbols: DBDMAT
9 months ago - InvestorPlace

Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gl...

10 months ago - Business Wire

Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucos...

10 months ago - Business Wire

Senseonics Announces Equity Grants to Employees Under Inducement Plan

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous ...

11 months ago - Business Wire

Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research